Microbiology & Virology
Read More about this categoryShow Less
Microbiology & Virology
A virus is a small infectious agent that replicates inside living cells. Viruses cause many human diseases from small illnesses, like influenza, to more deadly diseases, like hepatitis B and HIV. Our body’s immune system defends against viral infection by generating specific antibodies to bind to and neutralize viral particles and by cell mediated immunity that destroys infected host cells.
Research Areas
- Antibiotic(664)
- CCR5(2)
- CMV(30)
- gp120/CD4(4)
- HBV(92)
- HCV(147)
- HIV(419)
- HSV(105)
- Influenza virus(156)
- NA(7)
- Reverse Transcriptase(71)
- RSV(41)
- SRPK(6)
- SARS-CoV(188)
- Antifungal(46)
- Orthopoxvirus(4)
- Antimalaria(6)
- Beta-Lactamase(3)
- VEEV(1)
- Arenavirus(11)
- Bacterial(1574)
- Enterovirus(27)
- Filovirus(15)
- Fungal(433)
- Parasite(443)
- Virus Protease(79)
- Chicken Pox & Shingles(1)
- Chikungunya(1)
- Coronaviruses(34)
- Dengue(5)
- DNA & RNA Polymerase Inhibitors(10)
- Entry/Fusion Inhibitors(9)
- Epstein-Barr(1)
- Integrase Inhibitors(5)
- MERS(10)
- Rhinoviruses(3)
- West Nile Virus(1)
- Yellow Fever(2)
- Zika(2)
- COVID-19(41)
- Antiviral(2)
- Measles Virus(1)
Products Related to Microbiology & Virology(3940)
- GC71138NDM-1 inhibitor-3Purity: >99.00%
NDM-1 inhibitor-3 (Compound 89) is a New Delhi Metallo-β-lactamase-1 (NDM-1) inhibitor with a Ki of 4 μM.
- GC71142ATP synthase inhibitor 2CAS: 2814540-76-4Purity: >99.00%
ATP synthase inhibitor 2 is a Pseudomonas aeruginosa (PA) ATP synthase inhibitor (IC50=10 μg/mL).
- GC71221LeritrelvirCAS: 2923310-64-7
Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM.
- GC71228PomotrelvirCAS: 2713437-86-4Purity: >95.00%
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor.
- GC71238Antifungal agent 48CAS: 2142003-75-4
Antifungal agent 48 (Example 308) is an antifungal agent.
- GC71239Antifungal agent 49CAS: 1414861-21-4
Antifungal agent 49 (Example 112) is an antifungal agent.
- GC71247GRL-1720 TFAPurity: >94.00%
GRL-1720 TFA is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 value of 15 μM.
- GC71264MosnodenvirCAS: 2043343-94-6Purity: >99.00%
Mosnodenvir (JNJ-1802) is a pan-serotype dengue antiviral agent with a high barrier to resistance, and is safe and well-tolerated.
- GC71308SARS-CoV-2-IN-41CAS: 2920904-06-7Purity: >99.00%
SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CLpro inhibitor with an IC50 value of 0.022 µM.
- GC71314DNA gyrase B-IN-2Purity: >99.00%
DNA gyrase B-IN-2 (Compound E) is a 2-aminobenzothiazole-based DNA gyrase B inhibitor with promising activity against ESKAPE bacterial pathogens.
- GC71324SARS-CoV-2 3CLpro-IN-20CAS: 878985-00-3Purity: >97.00%
SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: 0.33 μM).
- GC71332Antimalarial agent 33Purity: >99.00%
Antimalarial agent 33 (compound 5g) has antiplasmodial activity against erythrocytic and hepatic stages of Plasmodium with an EC50 of 1.1 μM for K1 P. falciparum strain.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC71131 | Ristocetin | 1404-55-3 | >98.00% | |
Ristocetin is a glycopeptide antibiotic. | ||||
| GC71138 | NDM-1 inhibitor-3 | - | >99.00% | |
NDM-1 inhibitor-3 (Compound 89) is a New Delhi Metallo-β-lactamase-1 (NDM-1) inhibitor with a Ki of 4 μM. | ||||
| GC71142 | ATP synthase inhibitor 2 | 2814540-76-4 | >99.00% | |
ATP synthase inhibitor 2 is a Pseudomonas aeruginosa (PA) ATP synthase inhibitor (IC50=10 μg/mL). | ||||
| GC71194 | LY1 | 2883813-32-7 | >98.00% | |
LY1 is a potent, selective and covalent inhibitor against both SARS-CoV-2 PLpro and Mpro with Kd values of 1.5 μM and 2.3 μM for Mpro C145A protein and PLpro C111A protein, respectively. | ||||
| GC71202 | Antibacterial agent 131 | - | >98.00% | |
Antibacterial agent 131 is a quinoline derivative. | ||||
| GC71221 | Leritrelvir | 2923310-64-7 | - | |
Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM. | ||||
| GC71227 | PYR01 | 2560576-15-8 | >98.00% | |
PYR01 is a potent HIV-1 nonnucleoside reverse transcriptase inhibitor. | ||||
| GC71228 | Pomotrelvir | 2713437-86-4 | >95.00% | |
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. | ||||
| GC71234 | IpOHA | 132418-03-2 | >98.00% | |
IpOHA is a potent plant KARI inhibitor. | ||||
| GC71238 | Antifungal agent 48 | 2142003-75-4 | - | |
Antifungal agent 48 (Example 308) is an antifungal agent. | ||||
| GC71239 | Antifungal agent 49 | 1414861-21-4 | - | |
Antifungal agent 49 (Example 112) is an antifungal agent. | ||||
| GC71244 | UC-781 | 178870-32-1 | - | |
UC-781 (NSC 675186) is a highly potent and selective nonnucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 with an IC50 value of 5 nM. | ||||
| GC71247 | GRL-1720 TFA | - | >94.00% | |
GRL-1720 TFA is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 value of 15 μM. | ||||
| GC71253 | ARC7 | 681212-58-8 | >99.00% | |
ARC7 can act as a probe for secondary metabolism in S. coelicolor. | ||||
| GC71264 | Mosnodenvir | 2043343-94-6 | >99.00% | |
Mosnodenvir (JNJ-1802) is a pan-serotype dengue antiviral agent with a high barrier to resistance, and is safe and well-tolerated. | ||||
| GC71273 | C12-TLRa | - | >99.00% | |
C12-TLRa is an adjuvant lipidoid. | ||||
| GC71308 | SARS-CoV-2-IN-41 | 2920904-06-7 | >99.00% | |
SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CLpro inhibitor with an IC50 value of 0.022 µM. | ||||
| GC71314 | DNA gyrase B-IN-2 | - | >99.00% | |
DNA gyrase B-IN-2 (Compound E) is a 2-aminobenzothiazole-based DNA gyrase B inhibitor with promising activity against ESKAPE bacterial pathogens. | ||||
| GC71318 | BDM91270 | 2892824-11-0 | >99.00% | |
BDM91270 (compound 29) is an E. coli AcrAB-TolC efflux pump inhibitor with an EC90 of 0.6 μM for wild-type E. coli AcrB. | ||||
| GC71319 | ND-011992 | 2446880-46-0 | >98.00% | |
ND-011992 is a reversible, selective quinazoline-type inhibitor targeting quinone reductases and quinol oxidases. | ||||
| GC71324 | SARS-CoV-2 3CLpro-IN-20 | 878985-00-3 | >97.00% | |
SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: 0.33 μM). | ||||
| GC71332 | Antimalarial agent 33 | - | >99.00% | |
Antimalarial agent 33 (compound 5g) has antiplasmodial activity against erythrocytic and hepatic stages of Plasmodium with an EC50 of 1.1 μM for K1 P. falciparum strain. | ||||
| GC71336 | SHEN26 | 2691076-98-7 | >99.00% | |
SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC50 for SARS-CoV-2 is 1.36 μM. | ||||
| GC71345 | JC-229 | 3026716-22-0 | >97.00% | |
JC-229 is a TbRPA1 inhibitor. | ||||